Delivery Order SPE2DB22D1200-SPE2DB24FN3TU

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tresiba Flextouch 200 unit/mL 3mL insulin pens. The fixed-price delivery order, valued at $5,464.29, has a period of performance through July 26, 2024. Amerisourcebergen, through its Corporate Office division, is providing these critical medical supplies to support military treatment facilities and other federal healthcare...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558479310 units of Tresiba FlexTouch insulin pens. The $2,376.48 firm fixed-price delivery order has a completion date of September 16, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order, valued at $5,458.35, is for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The contract has a completion date of August 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tresiba Flextouch 200 unit/mL 3mL insulin delivery pens. The single-award Delivery Order, valued at $15,711.19, has a firm fixed price and was not designated with a set-aside requirement. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. The award has a ceiling value of $3,602.79 and is a Firm Fixed Price Delivery Order contract with a completion date of September 24, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to support various...
This federal contract award is for the delivery of Tresiba FlexTouch insulin pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,484.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with a completion date of November 29, 2024. The contract is not designated as a set-aside and represents a direct procurement under AmerisourceBergen's existing Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tresiba FlexTouch 200 Unit/mL 3mL insulin products. The contract has a ceiling value of $3,682.76 and spans from the award date of August 28, 2024, through the ultimate completion date of August 29, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, through its Corporate Office...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $5,867.68 firm-fixed-price delivery order is for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The award does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award, valued at $30,789.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a delivery order (SPE2DX24F04SU) for the supply of Tresiba FlexTouch insulin pens, a critical medication for the treatment of diabetes. This award is not associated with any set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Tresiba Flextouch insulin pens. The $30,687.31 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen's Corporate Office division. The contract has an ultimate completion date of October 14, 2022. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN3TU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,352.79, is for the delivery of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. This is a firm-fixed price Delivery Order contract with a completion date of July 18, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract, which is part of the company's broader portfolio of federal contracts to supply essential pharmaceutical and medical products to various government agencies, including the military. This specific award supports the healthcare needs of military personnel and other federal beneficiaries.

Generated 10/16/24, 9:09 AM